SPARX PROTEIN Trademark

Trademark Overview

On Monday, April 6, 2020, a trademark application was filed for SPARX PROTEIN with the United States Patent and Trademark Office. The USPTO has given the SPARX PROTEIN trademark a serial number of 88861317. The federal status of this trademark filing is OPPOSITION PENDING as of Friday, October 11, 2024. This trademark is owned by Arcellx, Inc.. The SPARX PROTEIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for use in cancer treatment and immunotherapy; pharmaceutical preparations for the purpose of binding ligands using engineered polypeptides and receptors for use in cancer treatment and immunotherapy; none of the foregoing for gene therapy or for the diagnosis or treatment of genetic, retinal, or hematologic diseases and disorders
sparx protein

General Information

Serial Number88861317
Word MarkSPARX PROTEIN
Filing DateMonday, April 6, 2020
Status774 - OPPOSITION PENDING
Status DateFriday, October 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 16, 2024

Trademark Statements

Description of MarkThe mark consists of the phrase "SPARX PROTEIN" in stylized form.
Goods and ServicesPharmaceutical preparations for targeting tissues based on select tissue markers and ligands for use in cancer treatment and immunotherapy; pharmaceutical preparations for the purpose of binding ligands using engineered polypeptides and receptors for use in cancer treatment and immunotherapy; none of the foregoing for gene therapy or for the diagnosis or treatment of genetic, retinal, or hematologic diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PROTEIN"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 15, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArcellx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065
Party NameArcellx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065

Trademark Events

Event DateEvent Description
Wednesday, April 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 9, 2020NEW APPLICATION ENTERED
Wednesday, June 24, 2020ASSIGNED TO EXAMINER
Thursday, June 25, 2020NON-FINAL ACTION WRITTEN
Thursday, June 25, 2020NON-FINAL ACTION E-MAILED
Thursday, June 25, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 4, 2021SUSPENSION LETTER WRITTEN
Monday, January 4, 2021LETTER OF SUSPENSION E-MAILED
Monday, January 4, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 1, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 2, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, December 5, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, June 21, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, June 22, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, July 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 11, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, August 7, 2023NON-FINAL ACTION WRITTEN
Monday, August 7, 2023NON-FINAL ACTION E-MAILED
Monday, August 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 26, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, October 26, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, December 6, 2023ASSIGNED TO EXAMINER
Tuesday, February 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 13, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 13, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 8, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, October 11, 2024OPPOSITION INSTITUTED NO. 999999
Sunday, October 13, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

Related Keywords

protein sparx treatment immunotherapy pharmaceutical cancer ligands preparations therapy gene foregoing none